Management of chronic obstructive pulmonary disease: Moving beyond the asthma algorithm
For many years, chronic obstructive pulmonary disease (COPD) was considered a disease of fixed airflow obstruction for which there was no good treatment. Out of desperation and frustration, health care providers extrapolated from asthma to COPD, and standard asthma therapy was adopted without eviden...
Saved in:
| Published in | Journal of allergy and clinical immunology Vol. 124; no. 5; pp. 873 - 880 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
New York, NY
Mosby, Inc
01.11.2009
Elsevier Elsevier Limited |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0091-6749 1097-6825 1097-6825 |
| DOI | 10.1016/j.jaci.2009.09.040 |
Cover
| Abstract | For many years, chronic obstructive pulmonary disease (COPD) was considered a disease of fixed airflow obstruction for which there was no good treatment. Out of desperation and frustration, health care providers extrapolated from asthma to COPD, and standard asthma therapy was adopted without evidence for efficacy. In recent years, we have gained a better understanding of the pathophysiologic differences between asthma and COPD, and prospective controlled trials have provided a rationale for therapy. Smoking cessation is critically important, both as primary prevention and as an effective way to slow the decrease in lung function in patients with established disease. β
2-Adrenergic and anticholinergic agonists improve lung function and relieve symptoms in most patients. Tiotropium improves exercise tolerance and quality of life and reduces exacerbations and hospitalizations. The increase in lung function seen with tiotropium is sustained with continued use over at least 3 to 4 years. Inhaled corticosteroids decrease exacerbations and improve quality of life, and their effect seems greatest in patients with lower lung function and in exacerbation-prone patients. There is no evidence that inhaled corticosteroids alone affect mortality, despite the reduction in exacerbations and increased risk of pneumonia. In some patient populations, inhaled fluticasone, salmeterol, or the combination might slow the rate of loss of lung function.
Rather than reflexively using effective asthma therapy in the patient with COPD, current and future therapy for COPD is increasingly evidence based and targeted to specific inflammatory pathways that are important in patients with COPD. |
|---|---|
| AbstractList | For many years, chronic obstructive pulmonary disease (COPD) was considered a disease of fixed airflow obstruction for which there was no good treatment. Out of desperation and frustration, health care providers extrapolated from asthma to COPD, and standard asthma therapy was adopted without evidence for efficacy. In recent years, we have gained a better understanding of the pathophysiologic differences between asthma and COPD, and prospective controlled trials have provided a rationale for therapy. Smoking cessation is critically important, both as primary prevention and as an effective way to slow the decrease in lung function in patients with established disease. β2-Adrenergic and anticholinergic agonists improve lung function and relieve symptoms in most patients. Tiotropium improves exercise tolerance and quality of life and reduces exacerbations and hospitalizations. The increase in lung function seen with tiotropium is sustained with continued use over at least 3 to 4 years. Inhaled corticosteroids decrease exacerbations and improve quality of life, and their effect seems greatest in patients with lower lung function and in exacerbation-prone patients. There is no evidence that inhaled corticosteroids alone affect mortality, despite the reduction in exacerbations and increased risk of pneumonia. In some patient populations, inhaled fluticasone, salmeterol, or the combination might slow the rate of loss of lung function. Rather than reflexively using effective asthma therapy in the patient with COPD, current and future therapy for COPD is increasingly evidence based and targeted to specific inflammatory pathways that are important in patients with COPD. For many years, chronic obstructive pulmonary disease (COPD) was considered a disease of fixed airflow obstruction for which there was no good treatment. Out of desperation and frustration, health care providers extrapolated from asthma to COPD, and standard asthma therapy was adopted without evidence for efficacy. In recent years, we have gained a better understanding of the pathophysiologic differences between asthma and COPD, and prospective controlled trials have provided a rationale for therapy. Smoking cessation is critically important, both as primary prevention and as an effective way to slow the decrease in lung function in patients with established disease. beta sub(2-Adrenergic and anticholinergic agonists improve lung function and relieve symptoms in most patients. Tiotropium improves exercise tolerance and quality of life and reduces exacerbations and hospitalizations. The increase in lung function seen with tiotropium is sustained with continued use over at least 3 to 4 years. Inhaled corticosteroids decrease exacerbations and improve quality of life, and their effect seems greatest in patients with lower lung function and in exacerbation-prone patients. There is no evidence that inhaled corticosteroids alone affect mortality, despite the reduction in exacerbations and increased risk of pneumonia. In some patient populations, inhaled fluticasone, salmeterol, or the combination might slow the rate of loss of lung function. Rather than reflexively using effective asthma therapy in the patient with COPD, current and future therapy for COPD is increasingly evidence based and targeted to specific inflammatory pathways that are important in patients with COPD.) For many years, chronic obstructive pulmonary disease (COPD) was considered a disease of fixed airflow obstruction for which there was no good treatment. Out of desperation and frustration, health care providers extrapolated from asthma to COPD, and standard asthma therapy was adopted without evidence for efficacy. In recent years, we have gained a better understanding of the pathophysiologic differences between asthma and COPD, and prospective controlled trials have provided a rationale for therapy. Smoking cessation is critically important, both as primary prevention and as an effective way to slow the decrease in lung function in patients with established disease. beta(2)-Adrenergic and anticholinergic agonists improve lung function and relieve symptoms in most patients. Tiotropium improves exercise tolerance and quality of life and reduces exacerbations and hospitalizations. The increase in lung function seen with tiotropium is sustained with continued use over at least 3 to 4 years. Inhaled corticosteroids decrease exacerbations and improve quality of life, and their effect seems greatest in patients with lower lung function and in exacerbation-prone patients. There is no evidence that inhaled corticosteroids alone affect mortality, despite the reduction in exacerbations and increased risk of pneumonia. In some patient populations, inhaled fluticasone, salmeterol, or the combination might slow the rate of loss of lung function. Rather than reflexively using effective asthma therapy in the patient with COPD, current and future therapy for COPD is increasingly evidence based and targeted to specific inflammatory pathways that are important in patients with COPD. For many years, chronic obstructive pulmonary disease (COPD) was considered a disease of fixed airflow obstruction for which there was no good treatment. Out of desperation and frustration, health care providers extrapolated from asthma to COPD, and standard asthma therapy was adopted without evidence for efficacy. In recent years, we have gained a better understanding of the pathophysiologic differences between asthma and COPD, and prospective controlled trials have provided a rationale for therapy. Smoking cessation is critically important, both as primary prevention and as an effective way to slow the decrease in lung function in patients with established disease. b sub(2)-Adrenergic and anticholinergic agonists improve lung function and relieve symptoms in most patients. Tiotropium improves exercise tolerance and quality of life and reduces exacerbations and hospitalizations. The increase in lung function seen with tiotropium is sustained with continued use over at least 3 to 4 years. Inhaled corticosteroids decrease exacerbations and improve quality of life, and their effect seems greatest in patients with lower lung function and in exacerbation-prone patients. There is no evidence that inhaled corticosteroids alone affect mortality, despite the reduction in exacerbations and increased risk of pneumonia. In some patient populations, inhaled fluticasone, salmeterol, or the combination might slow the rate of loss of lung function. Rather than reflexively using effective asthma therapy in the patient with COPD, current and future therapy for COPD is increasingly evidence based and targeted to specific inflammatory pathways that are important in patients with COPD. For many years, chronic obstructive pulmonary disease (COPD) was considered a disease of fixed airflow obstruction for which there was no good treatment. Out of desperation and frustration, health care providers extrapolated from asthma to COPD, and standard asthma therapy was adopted without evidence for efficacy. In recent years, we have gained a better understanding of the pathophysiologic differences between asthma and COPD, and prospective controlled trials have provided a rationale for therapy. Smoking cessation is critically important, both as primary prevention and as an effective way to slow the decrease in lung function in patients with established disease. beta(2)-Adrenergic and anticholinergic agonists improve lung function and relieve symptoms in most patients. Tiotropium improves exercise tolerance and quality of life and reduces exacerbations and hospitalizations. The increase in lung function seen with tiotropium is sustained with continued use over at least 3 to 4 years. Inhaled corticosteroids decrease exacerbations and improve quality of life, and their effect seems greatest in patients with lower lung function and in exacerbation-prone patients. There is no evidence that inhaled corticosteroids alone affect mortality, despite the reduction in exacerbations and increased risk of pneumonia. In some patient populations, inhaled fluticasone, salmeterol, or the combination might slow the rate of loss of lung function. Rather than reflexively using effective asthma therapy in the patient with COPD, current and future therapy for COPD is increasingly evidence based and targeted to specific inflammatory pathways that are important in patients with COPD.For many years, chronic obstructive pulmonary disease (COPD) was considered a disease of fixed airflow obstruction for which there was no good treatment. Out of desperation and frustration, health care providers extrapolated from asthma to COPD, and standard asthma therapy was adopted without evidence for efficacy. In recent years, we have gained a better understanding of the pathophysiologic differences between asthma and COPD, and prospective controlled trials have provided a rationale for therapy. Smoking cessation is critically important, both as primary prevention and as an effective way to slow the decrease in lung function in patients with established disease. beta(2)-Adrenergic and anticholinergic agonists improve lung function and relieve symptoms in most patients. Tiotropium improves exercise tolerance and quality of life and reduces exacerbations and hospitalizations. The increase in lung function seen with tiotropium is sustained with continued use over at least 3 to 4 years. Inhaled corticosteroids decrease exacerbations and improve quality of life, and their effect seems greatest in patients with lower lung function and in exacerbation-prone patients. There is no evidence that inhaled corticosteroids alone affect mortality, despite the reduction in exacerbations and increased risk of pneumonia. In some patient populations, inhaled fluticasone, salmeterol, or the combination might slow the rate of loss of lung function. Rather than reflexively using effective asthma therapy in the patient with COPD, current and future therapy for COPD is increasingly evidence based and targeted to specific inflammatory pathways that are important in patients with COPD. For many years, chronic obstructive pulmonary disease (COPD) was considered a disease of fixed airflow obstruction for which there was no good treatment. Out of desperation and frustration, health care providers extrapolated from asthma to COPD, and standard asthma therapy was adopted without evidence for efficacy. In recent years, we have gained a better understanding of the pathophysiologic differences between asthma and COPD, and prospective controlled trials have provided a rationale for therapy. Smoking cessation is critically important, both as primary prevention and as an effective way to slow the decrease in lung function in patients with established disease. β 2-Adrenergic and anticholinergic agonists improve lung function and relieve symptoms in most patients. Tiotropium improves exercise tolerance and quality of life and reduces exacerbations and hospitalizations. The increase in lung function seen with tiotropium is sustained with continued use over at least 3 to 4 years. Inhaled corticosteroids decrease exacerbations and improve quality of life, and their effect seems greatest in patients with lower lung function and in exacerbation-prone patients. There is no evidence that inhaled corticosteroids alone affect mortality, despite the reduction in exacerbations and increased risk of pneumonia. In some patient populations, inhaled fluticasone, salmeterol, or the combination might slow the rate of loss of lung function. Rather than reflexively using effective asthma therapy in the patient with COPD, current and future therapy for COPD is increasingly evidence based and targeted to specific inflammatory pathways that are important in patients with COPD. |
| Author | Lazarus, Stephen C. Gordon, Erin |
| Author_xml | – sequence: 1 givenname: Erin surname: Gordon fullname: Gordon, Erin organization: Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, Calif – sequence: 2 givenname: Stephen C. surname: Lazarus fullname: Lazarus, Stephen C. email: lazma@ucsf.edu organization: Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, Calif |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22177575$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19895979$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkl2LEzEUhoOsuN3qH_BCBsT1qjXJzORjEUEWv2AXL1S8DGnmTJs6k3STTKH_fjO0rlCwCweSkOc95yTnvUBnzjtA6CXBc4IJe7eer7Wxc4qxnI9R4SdoQrDkMyZofYYm-YLMGK_kObqIcY3zuRTyGTonUshacjlBv2-100vowaXCt4VZBe-sKfwipjCYZLdQbIau906HXdHYCDrCVXHrt9YtiwXsvGuKtIJCx7TqdaG7pQ82b5-jp63uIrw4rFP06_Onn9dfZzffv3y7_ngzM7WgaUZEWZfACJeVqASFSrdS8kYvKON1TYWmrG5kywhhrSlFyQiULeUca6qZZrScorf7vJvg7waISfU2Gug67cAPUQnOaI1LWj1K8rIiVBI55rw8SVJCBJW58Sl6fQSu_RBcfq8iNa4EYZUsM_XqQA2LHhq1CbbPv6n-DiEDbw6AjkZ3bdDO2PjAUUo4r_lYTuw5E3yMAVplbNLJepeCtp0iWI2-UGs1-kKNvlBjVDhL6ZH0oYtTovd7EeQBbi0EFY0FZ6CxAUxSjben5R-O5Kaz2Vy6-wM7iP--SkWqsPoxunU0K5aYVLVkOcHV_xM8Vv0eMn72lQ |
| CODEN | JACIBY |
| CitedBy_id | crossref_primary_10_1111_crj_12123 crossref_primary_10_1097_IPC_0b013e3181df0d81 crossref_primary_10_1016_j_tube_2010_09_007 crossref_primary_10_1016_S0300_2896_10_70046_6 crossref_primary_10_1186_s40348_016_0044_8 crossref_primary_10_1016_j_jchromb_2011_09_027 crossref_primary_10_1080_20786204_2013_10874297 crossref_primary_10_1016_j_jpba_2024_116283 crossref_primary_10_1111_ijpp_12407 crossref_primary_10_3727_096368910X543385 crossref_primary_10_1097_ACI_0b013e32833d232e |
| Cites_doi | 10.7326/0003-4819-143-5-200509060-00007 10.1164/rccm.200510-1589OC 10.1136/thorax.57.8.694 10.1002/14651858.CD001495 10.1056/NEJM199409153311103 10.1183/09031936.04.00014304 10.1164/ajrccm.150.1.8025735 10.1164/ajrccm/146.2.389 10.1164/ajrccm.162.1.9909066 10.3109/02770909909075409 10.1016/S0140-6736(03)12891-7 10.1016/0002-9343(83)90623-X 10.1164/rccm.200511-1746OC 10.1183/09031936.04.00116004 10.1056/NEJMoa044113 10.1164/rccm.200610-1563OC 10.7326/0003-4819-142-4-200502150-00005 10.1183/09031936.02.00238702 10.1164/rccm.2007035 10.1056/NEJMct0804632 10.1002/14651858.CD003269.pub2 10.1056/NEJM200012283432601 10.1164/ajrccm.160.5.9811058 10.1034/j.1399-3003.2000.15.08.x 10.1378/chest.129.1.15 10.1016/S0140-6736(09)61252-6 10.1002/14651858.CD002991.pub2 10.1002/14651858.CD005374 10.1001/jama.285.20.2583 10.1164/ajrccm/142.4.832 10.1172/JCI36130 10.1056/NEJM199906243402503 10.7326/0003-4819-93-3-391 10.1136/thorax.58.5.399 10.1016/S0140-6736(05)66456-2 10.1164/ajrccm/146.3.800 10.1016/S0024-3205(98)00588-8 10.1001/jama.296.1.56 10.1056/NEJM199108083250603 10.1034/j.1399-3003.2000.16b12.x 10.1016/S0002-9343(02)01143-9 10.1164/rccm.200903-0488OC 10.1016/S0140-6736(05)67100-0 10.1136/thx.2007.081703 10.1002/14651858.CD003793.pub2 10.1056/NEJM199810223391703 10.1164/ajrccm/146.3.547 10.1002/14651858.CD001287.pub2 10.1164/rccm.200404-543OC 10.1378/chest.115.4.966 10.1183/09031936.04.00012704 10.1136/thx.2006.063271 10.1136/thx.2006.075937 10.1056/NEJM200008033430504 10.1016/j.rmed.2005.03.034 10.1164/ajrccm/146.1.76 10.1016/j.jaci.2008.07.029 10.1001/jama.2008.717 10.1016/S0140-6736(98)10019-3 10.1136/bmj.322.7297.1271 10.1056/NEJMoa063070 10.1164/rccm.200712-1869OC 10.1056/NEJM199211123272003 10.1183/09031936.00138707 10.1136/bmj.320.7245.1297 10.1164/rccm.2105025 10.1002/14651858.CD002733.pub2 10.1111/j.1365-2222.2008.03118.x 10.1186/1476-069X-4-7 10.1016/S0149-2918(00)88479-9 10.1056/NEJM199409223311206 10.1378/chest.128.3.1168 10.1016/S0140-6736(09)61255-1 10.1164/rccm.200309-1251OC 10.1001/jama.296.1.47 10.1136/thx.46.5.355 10.1001/jama.1994.03520190043033 10.1164/ajrccm.153.2.8564107 10.1016/S0140-6736(04)16855-4 10.1002/14651858.CD001116.pub2 10.1136/thx.52.8.674 10.1016/S0140-6736(00)02872-5 10.1016/j.rmed.2005.04.025 10.1378/chest.109.5.1156 10.1136/thx.2006.061457 10.1056/NEJMoa0805800 10.1002/14651858.CD000364.pub3 10.1081/COPD-120030163 10.1136/thx.2004.032516 10.1056/NEJMoa011961 10.1183/09031936.02.00269802 |
| ContentType | Journal Article |
| Copyright | 2009 American Academy of Allergy, Asthma & Immunology American Academy of Allergy, Asthma & Immunology 2015 INIST-CNRS Copyright Elsevier Limited Nov 2009 |
| Copyright_xml | – notice: 2009 American Academy of Allergy, Asthma & Immunology – notice: American Academy of Allergy, Asthma & Immunology – notice: 2015 INIST-CNRS – notice: Copyright Elsevier Limited Nov 2009 |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7SS 7T5 H94 K9. NAPCQ 7U7 C1K 7X8 |
| DOI | 10.1016/j.jaci.2009.09.040 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Entomology Abstracts (Full archive) Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Nursing & Allied Health Premium Toxicology Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Entomology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Immunology Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | Entomology Abstracts AIDS and Cancer Research Abstracts MEDLINE AIDS and Cancer Research Abstracts MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1097-6825 |
| EndPage | 880 |
| ExternalDocumentID | 3239340571 19895979 22177575 10_1016_j_jaci_2009_09_040 S0091674909014596 1_s2_0_S0091674909014596 |
| Genre | Journal Article Review |
| GroupedDBID | --- --K --M -~X .1- .55 .FO .GJ .XZ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 354 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8F7 8FE 8FH 8P~ 9JM AAAJQ AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFRT ADMUD ADNMO ADVLN ADXHL AEBSH AEIPS AEKER AENEX AEUPX AFFNX AFJKZ AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGEKW AGHFR AGQPQ AGUBO AGYEJ AHHHB AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV BPHCQ BVXVI C45 CAG CJTIS COF CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDU HMK HMO HVGLF HZ~ IHE J1W J5H K-O KOM L7B LK8 LUGTX M27 M41 MO0 N4W N9A O-L O9- O9~ OAUVE OBH ODZKP OHH OHT OK0 OK1 OVD OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SJN SPCBC SSH SSI SSZ T5K TEORI TWZ UGJ UNMZH UV1 WH7 WOW WUQ X7M XFW YOC YQI YQJ Z5R ZGI ZXP ZY1 ~02 ~G- ~KM AACTN RIG AAYXX ACLOT CITATION EFLBG ~HD AGRNS IQODW CGR CUY CVF ECM EIF NPM 7SS 7T5 H94 K9. NAPCQ 7U7 C1K 7X8 |
| ID | FETCH-LOGICAL-c582t-18353e617948482e4af997dab2675528a265d9f6116fc38361e3f2770a2a6a623 |
| IEDL.DBID | .~1 |
| ISSN | 0091-6749 1097-6825 |
| IngestDate | Sun Sep 28 02:00:07 EDT 2025 Sun Sep 28 07:05:36 EDT 2025 Mon Sep 29 05:30:05 EDT 2025 Wed Aug 13 09:46:44 EDT 2025 Mon Jul 21 05:49:01 EDT 2025 Mon Jul 21 09:12:01 EDT 2025 Wed Oct 01 05:09:10 EDT 2025 Thu Apr 24 23:05:29 EDT 2025 Sun Apr 06 06:54:18 EDT 2025 Wed Apr 02 07:43:50 EDT 2025 Tue Aug 26 17:58:54 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | ISOLDE OR antioxidants bronchodilators asthma oral corticosteroids FVC smoking cessation immunization mucolytics TORCH long-acting bronchodilators Chronic obstructive pulmonary disease airflow obstruction pulmonary rehabilitation anticholinergics home oxygen inhaled corticosteroids β 2-agonists COPD Forced vital capacity Towards a Revolution in COPD Health Odds ratio Inhaled Steroids in Obstructive Lung Disease Agonist Lung Vaccination Tobacco smoking Respiratory system Obstruction Immunology Bronchus disease Obstructive pulmonary disease Anticholinesterase agent Lung disease Corticosteroid Immunopathology Immunization Oxygen Poison withdrawal Respiratory disease Bronchodilator Oral administration Antioxidant Algorithm Asthma Inhalation Mucolytic β Clinical management agonists Shutdown Rehabilitation(human) Rehabilitation |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c582t-18353e617948482e4af997dab2675528a265d9f6116fc38361e3f2770a2a6a623 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 ObjectType-Review-3 |
| PMID | 19895979 |
| PQID | 1504816493 |
| PQPubID | 23462 |
| PageCount | 8 |
| ParticipantIDs | proquest_miscellaneous_876250324 proquest_miscellaneous_734129192 proquest_miscellaneous_21182935 proquest_journals_1504816493 pubmed_primary_19895979 pascalfrancis_primary_22177575 crossref_citationtrail_10_1016_j_jaci_2009_09_040 crossref_primary_10_1016_j_jaci_2009_09_040 elsevier_sciencedirect_doi_10_1016_j_jaci_2009_09_040 elsevier_clinicalkeyesjournals_1_s2_0_S0091674909014596 elsevier_clinicalkey_doi_10_1016_j_jaci_2009_09_040 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2009-11-01 |
| PublicationDateYYYYMMDD | 2009-11-01 |
| PublicationDate_xml | – month: 11 year: 2009 text: 2009-11-01 day: 01 |
| PublicationDecade | 2000 |
| PublicationPlace | New York, NY |
| PublicationPlace_xml | – name: New York, NY – name: United States – name: St. Louis |
| PublicationTitle | Journal of allergy and clinical immunology |
| PublicationTitleAlternate | J Allergy Clin Immunol |
| PublicationYear | 2009 |
| Publisher | Mosby, Inc Elsevier Elsevier Limited |
| Publisher_xml | – name: Mosby, Inc – name: Elsevier – name: Elsevier Limited |
| References | Vincken, van Noord, Greefhorst, Bantje, Kesten, Korducki (bib46) 2002; 19 Vestbo, Sorensen, Lange, Brix, Torre, Viskum (bib25) 1999; 353 Culpitt, Maziak, Loukidis, Nightingale, Matthews, Barnes (bib18) 1999; 160 Poole, Black (bib63) 2006 Brightling, McKenna, Hargadon, Birring, Green, Siva (bib19) 2005; 60 van Schayck, Folgering, Harbers, Maas, van Weel (bib42) 1991; 46 Casaburi, ZuWallack (bib92) 2009; 360 (bib76) 1981; 1 Alsaeedi, Sin, McAlister (bib31) 2002; 113 Althuis, Sexton, Prybylski (bib85) 1999; 36 Celli, Thomas, Anderson, Ferguson, Jenkins, Jones (bib30) 2008; 178 Chaudhuri, Livingston, McMahon, Lafferty, Fraser, Spears (bib78) 2006; 174 Hattotuwa, Gizycki, Ansari, Jeffery, Barnes (bib15) 2002; 165 Ozol, Aysan, Solak, Mogulkoc, Veral, Sebik (bib21) 2005; 99 van Essen-Zandvliet, Hughes, Waalkens, Duiverman, Pocock, Kerrebijn (bib10) 1992; 146 Lazarus, Chinchilli, Rollings, Boushey, Cherniack, Craig (bib89) 2007; 175 Fabbri, Pauwels, Hurd (bib32) 2004; 1 Siroux, Pin, Oryszczyn, Le Moual, Kauffmann (bib84) 2000; 15 Juniper, Kline, Vanzielehgem, Ramsdale, O'Byrne, Hargreave (bib12) 1990; 142 Barnes (bib7) 2008; 118 Westby, Benson, Gibson (bib41) 2004 Smith, Spina (bib69) 2005; 6 Renkema, Schouten, Koeter, Postma (bib37) 1996; 109 Disse, Speck, Rominger, Witek, Hammer (bib44) 1999; 64 Gorecka, Gorzelak, Sliwinski, Tobiasz, Zielinski (bib77) 1997; 52 Walters, Walters, Wood-Baker (bib38) 2005 Apostol, Jacobs, Tsai, Crow, Williams, Townsend (bib86) 2002; 166 Lange, Parner, Vestbo, Schnohr, Jensen (bib87) 1998; 339 Talbot, Hartert, Mitchel, Halasa, Arbogast, Poehling (bib101) 2005; 352 Decramer, Lacquet, Fagard, Rogiers (bib35) 1994; 150 Willemse, Postma, Timens, ten Hacken (bib6) 2004; 23 Verhoeven, Hegmans, Mulder, Bogaard, Hoogsteden, Prins (bib16) 2002; 57 Celli, MacNee (bib33) 2004; 23 Marquette, Saulnier, Leroy, Wallaert, Chopin, Demarcq (bib88) 1992; 146 Liu, Zhou, Wang, Wang, Lu, Zheng (bib4) 2007; 2007 Kerstjens, Brand, Hughes, Robinson, Postma, Sluiter (bib11) 1992; 327 Pauwels, Pedersen, Busse, Tan, Chen, Ohlsson (bib14) 2003; 361 (bib98) 2001; 345 Gonzales, Rennard, Nides, Oncken, Azoulay, Billing (bib90) 2006; 296 Grootendorst, Gauw, Verhoosel, Sterk, Hospers, Bredenbroker (bib70) 2007; 62 Sin, Lacy, York, Man (bib22) 2004; 170 Poole, Chacko, Wood-Baker, Cates (bib97) 2006 Barnes (bib45) 2000; 117 Appleton, Poole, Smith, Veale, Lasserson, Chan (bib60) 2006 O'Donnell, Fluge, Gerken, Hamilton, Webb, Aguilaniu (bib48) 2004; 23 Anthonisen, Skeans, Wise, Manfreda, Kanner, Connett (bib80) 2005; 142 Brightling, Monteiro, Ward (bib39) 2000; 356 Niewoehner, Rice, Cote, Paulson, Cooper, Korducki (bib51) 2005; 143 Burge, Calverley, Jones, Spencer, Anderson, Maslen (bib27) 2000; 320 Decramer, Stas (bib34) 1992; 146 Casaburi, Mahler, Jones, Wanner, San, ZuWallack (bib47) 2002; 19 Calverley, Sanchez-Toril, McIvor, Teichmann, Bredenbroeker, Fabbri (bib72) 2007; 176 (bib75) 1980; 93 Lacasse, Goldstein, Lasserson, Martin (bib94) 2006 Maltais, Hamilton, Marciniuk, Hernandez, Sciurba, Richter (bib49) 2005; 128 Bateman, Hurd, Barnes, Bousquet, Drazen, FitzGerald (bib59) 2008; 31 Nannini, Cates, Lasserson, Poole (bib61) 2007 Yang, Fong, Sim, Black, Lasserson (bib29) 2007 Anthonisen, Connett, Kiley, Altose, Bailey, Buist (bib79) 1994; 272 Dorinsky, Reisner, Ferguson, Menjoge, Serby, Witek (bib40) 1999; 115 Nelson, Weiss, Bleecker, Yancey, Dorinsky, Group (bib57) 2006; 129 John, Bosse, Oltmanns, Schumacher, Witt (bib23) 2005; 99 (bib58) 2007; 120 Appleton, Jones, Poole, Pilotto, Adams, Lasserson (bib43) 2006 Sestini, Renzoni, Robinson, Poole, Ram (bib54) 2002 Poole, Black (bib67) 2001; 322 (bib56) 2002; 110 Decramer, Rutten-van Molken, Dekhuijzen, Troosters, van Herwaarden, Pellegrino (bib68) 2005; 365 Brusasco, Hodder, Miravitlles, Korducki, Towse, Kesten (bib50) 2003; 58 Willart, Lambrecht (bib2) 2009; 39 Kanner, Renzetti, Stanish, Barkman, Klauber (bib82) 1983; 74 Llewellyn-Jones, Harris, Stockley (bib17) 1996; 153 Postma, Gimeno, van der Weele, Sluiter (bib83) 1985; 67 Adams, Bestall, Jones (bib5) 2000 Pauwels, Lofdahl, Laitinen, Schouten, Postma, Pride (bib26) 1999; 340 Calverley, Rabe, Goehring, Kristiansen, Fabbri, Martinez (bib74) 2009; 374 Rabe, Bateman, O'Donnell, Witte, Bredenbroker, Bethke (bib71) 2005; 366 Cates, Jefferson, Rowe (bib99) 2008 Haahtela, Järvinen, Kava, Kiviranta, Koskinen, Lehtonen (bib9) 1994; 331 Stey, Steurer, Bachmann, Medici, Tramer (bib66) 2000; 16 Eisner, Balmes, Katz, Trupin, Yelin, Blanc (bib3) 2005; 4 Drummond, Dasenbrook, Pitz, Murphy, Fan (bib24) 2008; 300 Barr, Bourbeau, Camargo, Ram (bib52) 2006; 61 Bueving, Bernsen, de Jongste, van Suijlekom-Smit, Rimmelzwaan, Osterhaus (bib100) 2004; 169 Haahtela, Järvinen, Kava, Kiviranta, Koskinen, Lehtonen (bib8) 1991; 325 Ries, Bauldoff, Carlin, Casaburi, Emery, Mahler (bib93) 2007; 131 Fabbri, Calverley, Izquierdo-Alonso, Bundschuh, Brose, Martinez (bib73) 2009; 374 Lazarus, Boushey, Fahy, Chinchilli, Lemanske, Sorkness (bib55) 2001; 285 Postma, de Vries, Koeter, Sluiter (bib81) 1986; 134 (bib28) 2000; 343 (bib103) 2009; 57 Thompson, Mueller, Heires, Bohling, Daughton, Yancey (bib20) 1992; 146 Nichol, Margolis, Wuorenma, Von Sternberg (bib96) 1994; 331 Jorenby, Hays, Rigotti, Azoulay, Watsky, Williams (bib91) 2006; 296 Juhn, Kita, Yawn, Boyle, Yoo, McGree (bib102) 2008; 122 Rice, Rubins, Lebahn, Parenti, Duane, Kuskowski (bib36) 2000; 162 Pauwels, Rabe (bib1) 2004; 364 Grandjean, Berthet, Ruffman, Leuenberger (bib65) 2000; 22 Ram, Robinson, Black, Picot (bib95) 2005 Dransfield, Nahm, Han, Harnden, Criner, Martinez (bib104) 2009; 180 Boogaard, Smit, Schornagel, Vaessen-Verberne, Kouwenberg, Hekkelaan (bib64) 2008; 63 Suissa, Ernst, Benayoun, Baltzan, Cai (bib13) 2000; 343 Calverley, Anderson, Celli, Ferguson, Jenkins, Jones (bib62) 2007; 356 Tashkin, Celli, Senn, Burkhart, Kesten, Menjoge (bib53) 2008; 359 Ram (10.1016/j.jaci.2009.09.040_bib95) 2005 Gorecka (10.1016/j.jaci.2009.09.040_bib77) 1997; 52 Yang (10.1016/j.jaci.2009.09.040_bib29) 2007 Vestbo (10.1016/j.jaci.2009.09.040_bib25) 1999; 353 Culpitt (10.1016/j.jaci.2009.09.040_bib18) 1999; 160 Calverley (10.1016/j.jaci.2009.09.040_bib62) 2007; 356 Chaudhuri (10.1016/j.jaci.2009.09.040_bib78) 2006; 174 Marquette (10.1016/j.jaci.2009.09.040_bib88) 1992; 146 Dransfield (10.1016/j.jaci.2009.09.040_bib104) 2009; 180 Vincken (10.1016/j.jaci.2009.09.040_bib46) 2002; 19 Appleton (10.1016/j.jaci.2009.09.040_bib43) 2006 (10.1016/j.jaci.2009.09.040_bib75) 1980; 93 Appleton (10.1016/j.jaci.2009.09.040_bib60) 2006 Lange (10.1016/j.jaci.2009.09.040_bib87) 1998; 339 Hattotuwa (10.1016/j.jaci.2009.09.040_bib15) 2002; 165 (10.1016/j.jaci.2009.09.040_bib76) 1981; 1 Poole (10.1016/j.jaci.2009.09.040_bib97) 2006 Nannini (10.1016/j.jaci.2009.09.040_bib61) 2007 Postma (10.1016/j.jaci.2009.09.040_bib81) 1986; 134 Casaburi (10.1016/j.jaci.2009.09.040_bib92) 2009; 360 Lazarus (10.1016/j.jaci.2009.09.040_bib89) 2007; 175 Ries (10.1016/j.jaci.2009.09.040_bib93) 2007; 131 Celli (10.1016/j.jaci.2009.09.040_bib30) 2008; 178 Siroux (10.1016/j.jaci.2009.09.040_bib84) 2000; 15 Casaburi (10.1016/j.jaci.2009.09.040_bib47) 2002; 19 Barr (10.1016/j.jaci.2009.09.040_bib52) 2006; 61 Alsaeedi (10.1016/j.jaci.2009.09.040_bib31) 2002; 113 Rice (10.1016/j.jaci.2009.09.040_bib36) 2000; 162 Walters (10.1016/j.jaci.2009.09.040_bib38) 2005 Sestini (10.1016/j.jaci.2009.09.040_bib54) 2002 Lacasse (10.1016/j.jaci.2009.09.040_bib94) 2006 van Essen-Zandvliet (10.1016/j.jaci.2009.09.040_bib10) 1992; 146 Adams (10.1016/j.jaci.2009.09.040_bib5) 2000 Llewellyn-Jones (10.1016/j.jaci.2009.09.040_bib17) 1996; 153 Brightling (10.1016/j.jaci.2009.09.040_bib39) 2000; 356 Brightling (10.1016/j.jaci.2009.09.040_bib19) 2005; 60 Apostol (10.1016/j.jaci.2009.09.040_bib86) 2002; 166 (10.1016/j.jaci.2009.09.040_bib28) 2000; 343 Niewoehner (10.1016/j.jaci.2009.09.040_bib51) 2005; 143 Kanner (10.1016/j.jaci.2009.09.040_bib82) 1983; 74 Haahtela (10.1016/j.jaci.2009.09.040_bib8) 1991; 325 Thompson (10.1016/j.jaci.2009.09.040_bib20) 1992; 146 Stey (10.1016/j.jaci.2009.09.040_bib66) 2000; 16 Decramer (10.1016/j.jaci.2009.09.040_bib35) 1994; 150 Disse (10.1016/j.jaci.2009.09.040_bib44) 1999; 64 Cates (10.1016/j.jaci.2009.09.040_bib99) 2008 Bateman (10.1016/j.jaci.2009.09.040_bib59) 2008; 31 (10.1016/j.jaci.2009.09.040_bib103) 2009; 57 Celli (10.1016/j.jaci.2009.09.040_bib33) 2004; 23 Nichol (10.1016/j.jaci.2009.09.040_bib96) 1994; 331 Suissa (10.1016/j.jaci.2009.09.040_bib13) 2000; 343 Ozol (10.1016/j.jaci.2009.09.040_bib21) 2005; 99 Eisner (10.1016/j.jaci.2009.09.040_bib3) 2005; 4 Juhn (10.1016/j.jaci.2009.09.040_bib102) 2008; 122 Pauwels (10.1016/j.jaci.2009.09.040_bib1) 2004; 364 John (10.1016/j.jaci.2009.09.040_bib23) 2005; 99 van Schayck (10.1016/j.jaci.2009.09.040_bib42) 1991; 46 Poole (10.1016/j.jaci.2009.09.040_bib63) 2006 Poole (10.1016/j.jaci.2009.09.040_bib67) 2001; 322 Rabe (10.1016/j.jaci.2009.09.040_bib71) 2005; 366 Anthonisen (10.1016/j.jaci.2009.09.040_bib79) 1994; 272 Jorenby (10.1016/j.jaci.2009.09.040_bib91) 2006; 296 Talbot (10.1016/j.jaci.2009.09.040_bib101) 2005; 352 Brusasco (10.1016/j.jaci.2009.09.040_bib50) 2003; 58 Liu (10.1016/j.jaci.2009.09.040_bib4) 2007; 2007 Calverley (10.1016/j.jaci.2009.09.040_bib74) 2009; 374 O'Donnell (10.1016/j.jaci.2009.09.040_bib48) 2004; 23 Lazarus (10.1016/j.jaci.2009.09.040_bib55) 2001; 285 (10.1016/j.jaci.2009.09.040_bib58) 2007; 120 (10.1016/j.jaci.2009.09.040_bib56) 2002; 110 Althuis (10.1016/j.jaci.2009.09.040_bib85) 1999; 36 Willart (10.1016/j.jaci.2009.09.040_bib2) 2009; 39 Drummond (10.1016/j.jaci.2009.09.040_bib24) 2008; 300 Burge (10.1016/j.jaci.2009.09.040_bib27) 2000; 320 Tashkin (10.1016/j.jaci.2009.09.040_bib53) 2008; 359 Fabbri (10.1016/j.jaci.2009.09.040_bib73) 2009; 374 Juniper (10.1016/j.jaci.2009.09.040_bib12) 1990; 142 Gonzales (10.1016/j.jaci.2009.09.040_bib90) 2006; 296 Decramer (10.1016/j.jaci.2009.09.040_bib34) 1992; 146 Grandjean (10.1016/j.jaci.2009.09.040_bib65) 2000; 22 Postma (10.1016/j.jaci.2009.09.040_bib83) 1985; 67 Fabbri (10.1016/j.jaci.2009.09.040_bib32) 2004; 1 Renkema (10.1016/j.jaci.2009.09.040_bib37) 1996; 109 Bueving (10.1016/j.jaci.2009.09.040_bib100) 2004; 169 Calverley (10.1016/j.jaci.2009.09.040_bib72) 2007; 176 Willemse (10.1016/j.jaci.2009.09.040_bib6) 2004; 23 Barnes (10.1016/j.jaci.2009.09.040_bib7) 2008; 118 Pauwels (10.1016/j.jaci.2009.09.040_bib26) 1999; 340 Kerstjens (10.1016/j.jaci.2009.09.040_bib11) 1992; 327 Haahtela (10.1016/j.jaci.2009.09.040_bib9) 1994; 331 Verhoeven (10.1016/j.jaci.2009.09.040_bib16) 2002; 57 Pauwels (10.1016/j.jaci.2009.09.040_bib14) 2003; 361 Nelson (10.1016/j.jaci.2009.09.040_bib57) 2006; 129 Smith (10.1016/j.jaci.2009.09.040_bib69) 2005; 6 Sin (10.1016/j.jaci.2009.09.040_bib22) 2004; 170 Barnes (10.1016/j.jaci.2009.09.040_bib45) 2000; 117 Decramer (10.1016/j.jaci.2009.09.040_bib68) 2005; 365 Grootendorst (10.1016/j.jaci.2009.09.040_bib70) 2007; 62 Westby (10.1016/j.jaci.2009.09.040_bib41) 2004 Dorinsky (10.1016/j.jaci.2009.09.040_bib40) 1999; 115 Boogaard (10.1016/j.jaci.2009.09.040_bib64) 2008; 63 (10.1016/j.jaci.2009.09.040_bib98) 2001; 345 Maltais (10.1016/j.jaci.2009.09.040_bib49) 2005; 128 Anthonisen (10.1016/j.jaci.2009.09.040_bib80) 2005; 142 |
| References_xml | – volume: 128 start-page: 1168 year: 2005 end-page: 1178 ident: bib49 article-title: Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD publication-title: Chest – volume: 22 start-page: 209 year: 2000 end-page: 221 ident: bib65 article-title: Efficacy of oral long-term N-acetylcysteine in bronchopulmonary disease: a meta-analysis of published double-blind placebo-controlled clinical trials publication-title: Clin Ther – volume: 62 start-page: 1081 year: 2007 end-page: 1087 ident: bib70 article-title: Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD publication-title: Thorax – year: 2004 ident: bib41 article-title: Anticholinergic agents for chronic asthma in adults publication-title: Cochrane Database Syst Rev – volume: 117 year: 2000 ident: bib45 article-title: The pharmacological properties of tiotropium publication-title: Chest – year: 2005 ident: bib38 article-title: Oral corticosteroids for stable chronic obstructive pulmonary disease publication-title: Cochrane Database Syst Rev – volume: 343 start-page: 332 year: 2000 end-page: 336 ident: bib13 article-title: Low-dose inhaled corticosteroids and the prevention of death from asthma publication-title: N Engl J Med – volume: 272 start-page: 1497 year: 1994 end-page: 1505 ident: bib79 article-title: Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study publication-title: JAMA – volume: 340 start-page: 1948 year: 1999 end-page: 1953 ident: bib26 article-title: Long-term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease publication-title: N Engl J Med – volume: 146 start-page: 800 year: 1992 end-page: 802 ident: bib34 article-title: Corticosteroid-induced myopathy involving respiratory muscles in patients with chronic obstructive pulmonary disease or asthma publication-title: Am Rev Respir Dis – year: 2005 ident: bib95 article-title: Physical training for asthma publication-title: Cochrane Database Syst Rev – volume: 2007 start-page: 889 year: 2007 end-page: 897 ident: bib4 article-title: Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China publication-title: Thorax – volume: 364 start-page: 613 year: 2004 end-page: 620 ident: bib1 article-title: Burden and clinical features of chronic obstructive pulmonary disease (COPD) publication-title: Lancet – volume: 165 start-page: 1592 year: 2002 end-page: 1596 ident: bib15 article-title: The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study publication-title: Am J Respir Crit Care Med – volume: 343 start-page: 1902 year: 2000 end-page: 1909 ident: bib28 article-title: Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease publication-title: N Engl J Med – volume: 285 start-page: 2583 year: 2001 end-page: 2593 ident: bib55 article-title: Long-Acting β2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma. A randomized controlled trial publication-title: JAMA – volume: 58 start-page: 399 year: 2003 end-page: 404 ident: bib50 article-title: Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD publication-title: Thorax – volume: 36 start-page: 257 year: 1999 end-page: 264 ident: bib85 article-title: Cigarette smoking and asthma symptom severity among adult asthmatics publication-title: J Asthma – volume: 296 start-page: 56 year: 2006 end-page: 63 ident: bib91 article-title: Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial publication-title: JAMA – volume: 166 start-page: 166 year: 2002 end-page: 172 ident: bib86 article-title: Early life factors contribute to the decrease in lung function between ages 18 and 40: the Coronary Artery Risk Development in Young Adults study publication-title: Am J Respir Crit Care Med – volume: 118 start-page: 3546 year: 2008 end-page: 3556 ident: bib7 article-title: The cytokine network in asthma and chronic obstructive pulmonary disease publication-title: J Clin Invest – volume: 146 start-page: 547 year: 1992 end-page: 554 ident: bib10 article-title: Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma publication-title: Am Rev Respir Dis – volume: 74 start-page: 249 year: 1983 end-page: 255 ident: bib82 article-title: Predictors of survival in subjects with chronic airflow limitation publication-title: Am J Med – volume: 122 start-page: 719 year: 2008 end-page: 723 ident: bib102 article-title: Increased risk of severe pneumococcal disease in patients with asthma publication-title: J Allergy Clin Immunol – year: 2007 ident: bib29 article-title: Inhaled corticosteroids for stable chronic obstructive pulmonary disease publication-title: Cochrane Database Syst Rev – volume: 52 start-page: 674 year: 1997 end-page: 679 ident: bib77 article-title: Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia publication-title: Thorax – volume: 170 start-page: 760 year: 2004 end-page: 765 ident: bib22 article-title: Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease publication-title: Am J Respir Crit Care Med – volume: 113 start-page: 59 year: 2002 end-page: 65 ident: bib31 article-title: The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials publication-title: Am J Med – volume: 175 start-page: 783 year: 2007 end-page: 790 ident: bib89 article-title: Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma publication-title: Am J Respir Crit Care Med – year: 2006 ident: bib97 article-title: Influenza vaccine for patients with chronic obstructive pulmonary disease publication-title: Cochrane Database Syst Rev – volume: 6 start-page: 1136 year: 2005 end-page: 1141 ident: bib69 article-title: Selective phosphodiesterase 4 inhibitors in the treatment of allergy and inflammation publication-title: Curr Opin Investig Drugs – year: 2006 ident: bib94 article-title: Pulmonary rehabilitation for chronic obstructive pulmonary disease publication-title: Cochrane Database Syst Rev – volume: 23 start-page: 464 year: 2004 end-page: 476 ident: bib6 article-title: The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation publication-title: Eur Respir J – volume: 129 start-page: 15 year: 2006 end-page: 26 ident: bib57 article-title: The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol publication-title: Chest – volume: 365 start-page: 1552 year: 2005 end-page: 1560 ident: bib68 article-title: Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo controlled trial publication-title: Lancet – volume: 150 start-page: 11 year: 1994 end-page: 16 ident: bib35 article-title: Corticosteroids contribute to muscle weakness in chronic airflow obstruction publication-title: Am J Respir Crit Care Med – volume: 19 start-page: 209 year: 2002 end-page: 216 ident: bib46 article-title: Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium publication-title: Eur Respir J – volume: 160 start-page: 1635 year: 1999 end-page: 1639 ident: bib18 article-title: Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease publication-title: Am J Respir Crit Care Med – volume: 180 start-page: 499 year: 2009 end-page: 505 ident: bib104 article-title: Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease publication-title: Am J Respir Crit Care Med – volume: 146 start-page: 389 year: 1992 end-page: 395 ident: bib20 article-title: Aerosolized beclomethasone in chronic bronchitis. Improved pulmonary function and diminished airway inflammation publication-title: Am Rev Respir Dis – volume: 142 start-page: 832 year: 1990 end-page: 836 ident: bib12 article-title: Effect of long-term treatment with an inhaled corticosteroid on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics publication-title: Am Rev Respir Dis – volume: 1 start-page: 105 year: 2004 end-page: 141 ident: bib32 article-title: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary updated 2003 publication-title: COPD – volume: 1 start-page: 681 year: 1981 end-page: 686 ident: bib76 article-title: Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party publication-title: Lancet – year: 2008 ident: bib99 article-title: Vaccines for preventing influenza in people with asthma publication-title: Cochrane Database Syst Rev – year: 2002 ident: bib54 article-title: Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease publication-title: Cochrane Database Syst Rev – volume: 374 start-page: 685 year: 2009 end-page: 694 ident: bib74 article-title: Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials publication-title: Lancet – volume: 353 start-page: 1819 year: 1999 end-page: 1823 ident: bib25 article-title: Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial publication-title: Lancet – volume: 19 start-page: 217 year: 2002 end-page: 224 ident: bib47 article-title: A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease publication-title: Eur Respir J – volume: 23 start-page: 832 year: 2004 end-page: 840 ident: bib48 article-title: Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD publication-title: Eur Respir J – volume: 356 start-page: 1480 year: 2000 end-page: 1485 ident: bib39 article-title: Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial publication-title: Lancet – volume: 361 start-page: 1071 year: 2003 end-page: 1076 ident: bib14 article-title: Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial publication-title: Lancet – volume: 322 start-page: 1271 year: 2001 end-page: 1274 ident: bib67 article-title: Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review publication-title: BMJ – volume: 327 start-page: 1413 year: 1992 end-page: 1419 ident: bib11 article-title: A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group publication-title: N Engl J Med – volume: 67 start-page: 360 year: 1985 end-page: 368 ident: bib83 article-title: Assessment of ventilatory variables in survival prediction of patients with chronic airflow obstruction: the importance of reversibility publication-title: Eur J Respir Dis – volume: 162 start-page: 174 year: 2000 end-page: 178 ident: bib36 article-title: Withdrawal of chronic systemic corticosteroids in patients with COPD: a randomized trial publication-title: Am J Respir Crit Care Med – volume: 146 start-page: 76 year: 1992 end-page: 81 ident: bib88 article-title: Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma publication-title: Am Rev Respir Dis – volume: 57 year: 2009 ident: bib103 article-title: Recommended adult immunization schedule—United States 2009 publication-title: MMWR – volume: 331 start-page: 700 year: 1994 end-page: 705 ident: bib9 article-title: Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma publication-title: N Engl J Med – volume: 142 start-page: 233 year: 2005 end-page: 239 ident: bib80 article-title: The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial publication-title: Ann Intern Med – volume: 4 start-page: 7 year: 2005 ident: bib3 article-title: Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease publication-title: Environ Health – volume: 64 start-page: 457 year: 1999 end-page: 464 ident: bib44 article-title: Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease publication-title: Life Sci – year: 2006 ident: bib43 article-title: Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease publication-title: Cochrane Database Syst Rev – volume: 57 start-page: 694 year: 2002 end-page: 700 ident: bib16 article-title: Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness publication-title: Thorax – year: 2006 ident: bib63 article-title: Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease publication-title: Cochrane Database Syst Rev – volume: 120 start-page: S94 year: 2007 end-page: S138 ident: bib58 article-title: Expert panel report 3 (EPR3): guidelines for diagnosis and management of asthma—summary report publication-title: J Allergy Clin Immunol – volume: 374 start-page: 695 year: 2009 end-page: 703 ident: bib73 article-title: Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials publication-title: Lancet – volume: 339 start-page: 1194 year: 1998 end-page: 1200 ident: bib87 article-title: A 15-year follow-up study of ventilatory function in adults with asthma publication-title: N Engl J Med – volume: 23 start-page: 932 year: 2004 end-page: 946 ident: bib33 article-title: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper publication-title: Eur Respir J – volume: 174 start-page: 127 year: 2006 end-page: 133 ident: bib78 article-title: Effects of smoking cessation on lung function and airway inflammation in smokers with asthma publication-title: Am J Respir Crit Care Med – volume: 31 start-page: 143 year: 2008 end-page: 178 ident: bib59 article-title: Global strategy for asthma management and prevention: GINA executive summary publication-title: Eur Respir J – year: 2000 ident: bib5 article-title: Inhaled beclomethasone versus placebo for chronic asthma publication-title: Cochrane Database Syst Rev – volume: 110 start-page: S141 year: 2002 end-page: S219 ident: bib56 article-title: Expert panel report: guidelines for the diagnosis and management of asthma update on selected topics—2002 publication-title: J Allergy Clin Immunol – volume: 39 start-page: 12 year: 2009 end-page: 19 ident: bib2 article-title: The danger within: endogenous danger signals, atopy and asthma publication-title: Clin Exp Allergy – volume: 134 start-page: 276 year: 1986 end-page: 280 ident: bib81 article-title: Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction publication-title: Am Rev Respir Dis – volume: 320 start-page: 1297 year: 2000 end-page: 1303 ident: bib27 article-title: Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial publication-title: BMJ – year: 2006 ident: bib60 article-title: Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease publication-title: Cochrane Database Syst Rev – volume: 46 start-page: 355 year: 1991 end-page: 359 ident: bib42 article-title: Effects of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis publication-title: Thorax – volume: 366 start-page: 563 year: 2005 end-page: 571 ident: bib71 article-title: Roflumilast—an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial publication-title: Lancet – volume: 15 start-page: 470 year: 2000 end-page: 477 ident: bib84 article-title: Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the Genetics and Environment of Asthma publication-title: Eur Respir J – volume: 16 start-page: 253 year: 2000 end-page: 262 ident: bib66 article-title: The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review publication-title: Eur Respir J – volume: 352 start-page: 2082 year: 2005 end-page: 2090 ident: bib101 article-title: Asthma as a risk factor for invasive pneumococcal disease publication-title: N Engl J Med – volume: 331 start-page: 778 year: 1994 end-page: 784 ident: bib96 article-title: The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community publication-title: N Engl J Med – volume: 109 start-page: 1156 year: 1996 end-page: 1162 ident: bib37 article-title: Effects of long-term treatment with corticosteroids in COPD publication-title: Chest – volume: 296 start-page: 47 year: 2006 end-page: 55 ident: bib90 article-title: Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial publication-title: JAMA – volume: 325 start-page: 388 year: 1991 end-page: 392 ident: bib8 article-title: Comparison of a β2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma publication-title: N Engl J Med – volume: 300 start-page: 2407 year: 2008 end-page: 2416 ident: bib24 article-title: Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis publication-title: JAMA – volume: 93 start-page: 391 year: 1980 end-page: 398 ident: bib75 article-title: Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial publication-title: Ann Intern Med – volume: 115 start-page: 966 year: 1999 end-page: 971 ident: bib40 article-title: The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD publication-title: Chest – volume: 345 start-page: 1529 year: 2001 end-page: 1536 ident: bib98 article-title: The ALA Asthma Clinical Research Centers. The safety of inactivated influenza vaccine in adults and children with asthma publication-title: N Engl J Med – volume: 169 start-page: 488 year: 2004 end-page: 493 ident: bib100 article-title: Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial publication-title: Am J Respir Crit Care Med – volume: 61 start-page: 854 year: 2006 end-page: 862 ident: bib52 article-title: Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis publication-title: Thorax – year: 2007 ident: bib61 article-title: Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease publication-title: Cochrane Database Syst Rev – volume: 360 start-page: 1329 year: 2009 end-page: 1335 ident: bib92 article-title: Pulmonary rehabilitation for management of chronic obstructive pulmonary disease publication-title: N Engl J Med – volume: 178 start-page: 332 year: 2008 end-page: 338 ident: bib30 article-title: Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study publication-title: Am J Respir Crit Care Med – volume: 60 start-page: 193 year: 2005 end-page: 198 ident: bib19 article-title: Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease publication-title: Thorax – volume: 359 start-page: 1543 year: 2008 end-page: 1554 ident: bib53 article-title: A 4-year trial of tiotropium in chronic obstructive pulmonary disease publication-title: N Engl J Med – volume: 143 start-page: 317 year: 2005 end-page: 326 ident: bib51 article-title: Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial publication-title: Ann Intern Med – volume: 63 start-page: 141 year: 2008 end-page: 146 ident: bib64 article-title: Recombinant human deoxyribonuclease for the treatment of acute asthma in children publication-title: Thorax – volume: 99 start-page: 1418 year: 2005 end-page: 1424 ident: bib23 article-title: Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease publication-title: Respir Med – volume: 176 start-page: 154 year: 2007 end-page: 161 ident: bib72 article-title: Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease publication-title: Am J Respir Crit Care Med – volume: 99 start-page: 1494 year: 2005 end-page: 1500 ident: bib21 article-title: The effect of inhaled corticosteroids on bronchoalveolar lavage cells and IL-8 levels in stable COPD patients publication-title: Respir Med – volume: 153 start-page: 616 year: 1996 end-page: 621 ident: bib17 article-title: Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema publication-title: Am J Respir Crit Care Med – volume: 131 year: 2007 ident: bib93 article-title: Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines publication-title: Chest – volume: 356 start-page: 775 year: 2007 end-page: 789 ident: bib62 article-title: Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease publication-title: N Engl J Med – volume: 143 start-page: 317 year: 2005 ident: 10.1016/j.jaci.2009.09.040_bib51 article-title: Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial publication-title: Ann Intern Med doi: 10.7326/0003-4819-143-5-200509060-00007 – volume: 174 start-page: 127 year: 2006 ident: 10.1016/j.jaci.2009.09.040_bib78 article-title: Effects of smoking cessation on lung function and airway inflammation in smokers with asthma publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200510-1589OC – volume: 57 start-page: 694 year: 2002 ident: 10.1016/j.jaci.2009.09.040_bib16 article-title: Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness publication-title: Thorax doi: 10.1136/thorax.57.8.694 – year: 2002 ident: 10.1016/j.jaci.2009.09.040_bib54 article-title: Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD001495 – volume: 331 start-page: 700 year: 1994 ident: 10.1016/j.jaci.2009.09.040_bib9 article-title: Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma publication-title: N Engl J Med doi: 10.1056/NEJM199409153311103 – volume: 23 start-page: 932 year: 2004 ident: 10.1016/j.jaci.2009.09.040_bib33 article-title: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper publication-title: Eur Respir J doi: 10.1183/09031936.04.00014304 – volume: 150 start-page: 11 year: 1994 ident: 10.1016/j.jaci.2009.09.040_bib35 article-title: Corticosteroids contribute to muscle weakness in chronic airflow obstruction publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.150.1.8025735 – volume: 146 start-page: 389 year: 1992 ident: 10.1016/j.jaci.2009.09.040_bib20 article-title: Aerosolized beclomethasone in chronic bronchitis. Improved pulmonary function and diminished airway inflammation publication-title: Am Rev Respir Dis doi: 10.1164/ajrccm/146.2.389 – volume: 162 start-page: 174 year: 2000 ident: 10.1016/j.jaci.2009.09.040_bib36 article-title: Withdrawal of chronic systemic corticosteroids in patients with COPD: a randomized trial publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.162.1.9909066 – volume: 36 start-page: 257 year: 1999 ident: 10.1016/j.jaci.2009.09.040_bib85 article-title: Cigarette smoking and asthma symptom severity among adult asthmatics publication-title: J Asthma doi: 10.3109/02770909909075409 – volume: 361 start-page: 1071 year: 2003 ident: 10.1016/j.jaci.2009.09.040_bib14 article-title: Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial publication-title: Lancet doi: 10.1016/S0140-6736(03)12891-7 – volume: 74 start-page: 249 year: 1983 ident: 10.1016/j.jaci.2009.09.040_bib82 article-title: Predictors of survival in subjects with chronic airflow limitation publication-title: Am J Med doi: 10.1016/0002-9343(83)90623-X – volume: 131 issue: suppl year: 2007 ident: 10.1016/j.jaci.2009.09.040_bib93 article-title: Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines publication-title: Chest – volume: 175 start-page: 783 year: 2007 ident: 10.1016/j.jaci.2009.09.040_bib89 article-title: Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200511-1746OC – volume: 23 start-page: 832 year: 2004 ident: 10.1016/j.jaci.2009.09.040_bib48 article-title: Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD publication-title: Eur Respir J doi: 10.1183/09031936.04.00116004 – volume: 352 start-page: 2082 year: 2005 ident: 10.1016/j.jaci.2009.09.040_bib101 article-title: Asthma as a risk factor for invasive pneumococcal disease publication-title: N Engl J Med doi: 10.1056/NEJMoa044113 – volume: 176 start-page: 154 year: 2007 ident: 10.1016/j.jaci.2009.09.040_bib72 article-title: Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200610-1563OC – volume: 142 start-page: 233 year: 2005 ident: 10.1016/j.jaci.2009.09.040_bib80 article-title: The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial publication-title: Ann Intern Med doi: 10.7326/0003-4819-142-4-200502150-00005 – volume: 117 issue: suppl year: 2000 ident: 10.1016/j.jaci.2009.09.040_bib45 article-title: The pharmacological properties of tiotropium publication-title: Chest – volume: 19 start-page: 209 year: 2002 ident: 10.1016/j.jaci.2009.09.040_bib46 article-title: Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium publication-title: Eur Respir J doi: 10.1183/09031936.02.00238702 – volume: 166 start-page: 166 year: 2002 ident: 10.1016/j.jaci.2009.09.040_bib86 article-title: Early life factors contribute to the decrease in lung function between ages 18 and 40: the Coronary Artery Risk Development in Young Adults study publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.2007035 – volume: 360 start-page: 1329 year: 2009 ident: 10.1016/j.jaci.2009.09.040_bib92 article-title: Pulmonary rehabilitation for management of chronic obstructive pulmonary disease publication-title: N Engl J Med doi: 10.1056/NEJMct0804632 – year: 2004 ident: 10.1016/j.jaci.2009.09.040_bib41 article-title: Anticholinergic agents for chronic asthma in adults publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD003269.pub2 – volume: 6 start-page: 1136 year: 2005 ident: 10.1016/j.jaci.2009.09.040_bib69 article-title: Selective phosphodiesterase 4 inhibitors in the treatment of allergy and inflammation publication-title: Curr Opin Investig Drugs – volume: 343 start-page: 1902 year: 2000 ident: 10.1016/j.jaci.2009.09.040_bib28 article-title: Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease publication-title: N Engl J Med doi: 10.1056/NEJM200012283432601 – volume: 160 start-page: 1635 year: 1999 ident: 10.1016/j.jaci.2009.09.040_bib18 article-title: Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.160.5.9811058 – volume: 15 start-page: 470 year: 2000 ident: 10.1016/j.jaci.2009.09.040_bib84 article-title: Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the Genetics and Environment of Asthma publication-title: Eur Respir J doi: 10.1034/j.1399-3003.2000.15.08.x – year: 2006 ident: 10.1016/j.jaci.2009.09.040_bib43 article-title: Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease publication-title: Cochrane Database Syst Rev – volume: 129 start-page: 15 year: 2006 ident: 10.1016/j.jaci.2009.09.040_bib57 article-title: The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol publication-title: Chest doi: 10.1378/chest.129.1.15 – volume: 374 start-page: 695 year: 2009 ident: 10.1016/j.jaci.2009.09.040_bib73 article-title: Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials publication-title: Lancet doi: 10.1016/S0140-6736(09)61252-6 – year: 2007 ident: 10.1016/j.jaci.2009.09.040_bib61 article-title: Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease publication-title: Cochrane Database Syst Rev – year: 2007 ident: 10.1016/j.jaci.2009.09.040_bib29 article-title: Inhaled corticosteroids for stable chronic obstructive pulmonary disease publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD002991.pub2 – year: 2005 ident: 10.1016/j.jaci.2009.09.040_bib38 article-title: Oral corticosteroids for stable chronic obstructive pulmonary disease publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD005374 – volume: 285 start-page: 2583 year: 2001 ident: 10.1016/j.jaci.2009.09.040_bib55 article-title: Long-Acting β2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma. A randomized controlled trial publication-title: JAMA doi: 10.1001/jama.285.20.2583 – volume: 142 start-page: 832 year: 1990 ident: 10.1016/j.jaci.2009.09.040_bib12 article-title: Effect of long-term treatment with an inhaled corticosteroid on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics publication-title: Am Rev Respir Dis doi: 10.1164/ajrccm/142.4.832 – volume: 118 start-page: 3546 year: 2008 ident: 10.1016/j.jaci.2009.09.040_bib7 article-title: The cytokine network in asthma and chronic obstructive pulmonary disease publication-title: J Clin Invest doi: 10.1172/JCI36130 – volume: 340 start-page: 1948 year: 1999 ident: 10.1016/j.jaci.2009.09.040_bib26 article-title: Long-term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease publication-title: N Engl J Med doi: 10.1056/NEJM199906243402503 – volume: 93 start-page: 391 year: 1980 ident: 10.1016/j.jaci.2009.09.040_bib75 article-title: Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial publication-title: Ann Intern Med doi: 10.7326/0003-4819-93-3-391 – volume: 58 start-page: 399 year: 2003 ident: 10.1016/j.jaci.2009.09.040_bib50 article-title: Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD publication-title: Thorax doi: 10.1136/thorax.58.5.399 – volume: 365 start-page: 1552 year: 2005 ident: 10.1016/j.jaci.2009.09.040_bib68 article-title: Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(05)66456-2 – volume: 146 start-page: 800 year: 1992 ident: 10.1016/j.jaci.2009.09.040_bib34 article-title: Corticosteroid-induced myopathy involving respiratory muscles in patients with chronic obstructive pulmonary disease or asthma publication-title: Am Rev Respir Dis doi: 10.1164/ajrccm/146.3.800 – volume: 64 start-page: 457 year: 1999 ident: 10.1016/j.jaci.2009.09.040_bib44 article-title: Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease publication-title: Life Sci doi: 10.1016/S0024-3205(98)00588-8 – volume: 296 start-page: 56 year: 2006 ident: 10.1016/j.jaci.2009.09.040_bib91 article-title: Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial publication-title: JAMA doi: 10.1001/jama.296.1.56 – volume: 325 start-page: 388 year: 1991 ident: 10.1016/j.jaci.2009.09.040_bib8 article-title: Comparison of a β2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma publication-title: N Engl J Med doi: 10.1056/NEJM199108083250603 – volume: 16 start-page: 253 year: 2000 ident: 10.1016/j.jaci.2009.09.040_bib66 article-title: The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review publication-title: Eur Respir J doi: 10.1034/j.1399-3003.2000.16b12.x – volume: 113 start-page: 59 year: 2002 ident: 10.1016/j.jaci.2009.09.040_bib31 article-title: The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials publication-title: Am J Med doi: 10.1016/S0002-9343(02)01143-9 – volume: 180 start-page: 499 year: 2009 ident: 10.1016/j.jaci.2009.09.040_bib104 article-title: Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200903-0488OC – volume: 366 start-page: 563 year: 2005 ident: 10.1016/j.jaci.2009.09.040_bib71 article-title: Roflumilast—an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(05)67100-0 – volume: 63 start-page: 141 year: 2008 ident: 10.1016/j.jaci.2009.09.040_bib64 article-title: Recombinant human deoxyribonuclease for the treatment of acute asthma in children publication-title: Thorax doi: 10.1136/thx.2007.081703 – year: 2006 ident: 10.1016/j.jaci.2009.09.040_bib94 article-title: Pulmonary rehabilitation for chronic obstructive pulmonary disease publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD003793.pub2 – volume: 339 start-page: 1194 year: 1998 ident: 10.1016/j.jaci.2009.09.040_bib87 article-title: A 15-year follow-up study of ventilatory function in adults with asthma publication-title: N Engl J Med doi: 10.1056/NEJM199810223391703 – volume: 134 start-page: 276 year: 1986 ident: 10.1016/j.jaci.2009.09.040_bib81 article-title: Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction publication-title: Am Rev Respir Dis – volume: 146 start-page: 547 year: 1992 ident: 10.1016/j.jaci.2009.09.040_bib10 article-title: Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma publication-title: Am Rev Respir Dis doi: 10.1164/ajrccm/146.3.547 – year: 2006 ident: 10.1016/j.jaci.2009.09.040_bib63 article-title: Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD001287.pub2 – volume: 170 start-page: 760 year: 2004 ident: 10.1016/j.jaci.2009.09.040_bib22 article-title: Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200404-543OC – volume: 115 start-page: 966 year: 1999 ident: 10.1016/j.jaci.2009.09.040_bib40 article-title: The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD publication-title: Chest doi: 10.1378/chest.115.4.966 – year: 2000 ident: 10.1016/j.jaci.2009.09.040_bib5 article-title: Inhaled beclomethasone versus placebo for chronic asthma publication-title: Cochrane Database Syst Rev – volume: 23 start-page: 464 year: 2004 ident: 10.1016/j.jaci.2009.09.040_bib6 article-title: The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation publication-title: Eur Respir J doi: 10.1183/09031936.04.00012704 – volume: 61 start-page: 854 year: 2006 ident: 10.1016/j.jaci.2009.09.040_bib52 article-title: Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis publication-title: Thorax doi: 10.1136/thx.2006.063271 – volume: 62 start-page: 1081 year: 2007 ident: 10.1016/j.jaci.2009.09.040_bib70 article-title: Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD publication-title: Thorax doi: 10.1136/thx.2006.075937 – volume: 343 start-page: 332 year: 2000 ident: 10.1016/j.jaci.2009.09.040_bib13 article-title: Low-dose inhaled corticosteroids and the prevention of death from asthma publication-title: N Engl J Med doi: 10.1056/NEJM200008033430504 – volume: 99 start-page: 1418 year: 2005 ident: 10.1016/j.jaci.2009.09.040_bib23 article-title: Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease publication-title: Respir Med doi: 10.1016/j.rmed.2005.03.034 – year: 2006 ident: 10.1016/j.jaci.2009.09.040_bib60 article-title: Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease publication-title: Cochrane Database Syst Rev – volume: 146 start-page: 76 year: 1992 ident: 10.1016/j.jaci.2009.09.040_bib88 article-title: Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma publication-title: Am Rev Respir Dis doi: 10.1164/ajrccm/146.1.76 – volume: 67 start-page: 360 year: 1985 ident: 10.1016/j.jaci.2009.09.040_bib83 article-title: Assessment of ventilatory variables in survival prediction of patients with chronic airflow obstruction: the importance of reversibility publication-title: Eur J Respir Dis – volume: 120 start-page: S94 issue: suppl year: 2007 ident: 10.1016/j.jaci.2009.09.040_bib58 article-title: Expert panel report 3 (EPR3): guidelines for diagnosis and management of asthma—summary report publication-title: J Allergy Clin Immunol – volume: 122 start-page: 719 year: 2008 ident: 10.1016/j.jaci.2009.09.040_bib102 article-title: Increased risk of severe pneumococcal disease in patients with asthma publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2008.07.029 – volume: 300 start-page: 2407 year: 2008 ident: 10.1016/j.jaci.2009.09.040_bib24 article-title: Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis publication-title: JAMA doi: 10.1001/jama.2008.717 – volume: 353 start-page: 1819 year: 1999 ident: 10.1016/j.jaci.2009.09.040_bib25 article-title: Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(98)10019-3 – volume: 322 start-page: 1271 year: 2001 ident: 10.1016/j.jaci.2009.09.040_bib67 article-title: Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review publication-title: BMJ doi: 10.1136/bmj.322.7297.1271 – volume: 356 start-page: 775 year: 2007 ident: 10.1016/j.jaci.2009.09.040_bib62 article-title: Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease publication-title: N Engl J Med doi: 10.1056/NEJMoa063070 – volume: 178 start-page: 332 year: 2008 ident: 10.1016/j.jaci.2009.09.040_bib30 article-title: Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200712-1869OC – volume: 1 start-page: 681 year: 1981 ident: 10.1016/j.jaci.2009.09.040_bib76 article-title: Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party publication-title: Lancet – volume: 327 start-page: 1413 year: 1992 ident: 10.1016/j.jaci.2009.09.040_bib11 article-title: A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group publication-title: N Engl J Med doi: 10.1056/NEJM199211123272003 – volume: 31 start-page: 143 year: 2008 ident: 10.1016/j.jaci.2009.09.040_bib59 article-title: Global strategy for asthma management and prevention: GINA executive summary publication-title: Eur Respir J doi: 10.1183/09031936.00138707 – volume: 320 start-page: 1297 year: 2000 ident: 10.1016/j.jaci.2009.09.040_bib27 article-title: Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial publication-title: BMJ doi: 10.1136/bmj.320.7245.1297 – volume: 165 start-page: 1592 year: 2002 ident: 10.1016/j.jaci.2009.09.040_bib15 article-title: The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.2105025 – year: 2006 ident: 10.1016/j.jaci.2009.09.040_bib97 article-title: Influenza vaccine for patients with chronic obstructive pulmonary disease publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD002733.pub2 – volume: 39 start-page: 12 year: 2009 ident: 10.1016/j.jaci.2009.09.040_bib2 article-title: The danger within: endogenous danger signals, atopy and asthma publication-title: Clin Exp Allergy doi: 10.1111/j.1365-2222.2008.03118.x – volume: 4 start-page: 7 year: 2005 ident: 10.1016/j.jaci.2009.09.040_bib3 article-title: Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease publication-title: Environ Health doi: 10.1186/1476-069X-4-7 – volume: 110 start-page: S141 issue: suppl year: 2002 ident: 10.1016/j.jaci.2009.09.040_bib56 article-title: Expert panel report: guidelines for the diagnosis and management of asthma update on selected topics—2002 publication-title: J Allergy Clin Immunol – volume: 22 start-page: 209 year: 2000 ident: 10.1016/j.jaci.2009.09.040_bib65 article-title: Efficacy of oral long-term N-acetylcysteine in bronchopulmonary disease: a meta-analysis of published double-blind placebo-controlled clinical trials publication-title: Clin Ther doi: 10.1016/S0149-2918(00)88479-9 – volume: 331 start-page: 778 year: 1994 ident: 10.1016/j.jaci.2009.09.040_bib96 article-title: The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community publication-title: N Engl J Med doi: 10.1056/NEJM199409223311206 – volume: 128 start-page: 1168 year: 2005 ident: 10.1016/j.jaci.2009.09.040_bib49 article-title: Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD publication-title: Chest doi: 10.1378/chest.128.3.1168 – volume: 374 start-page: 685 year: 2009 ident: 10.1016/j.jaci.2009.09.040_bib74 article-title: Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials publication-title: Lancet doi: 10.1016/S0140-6736(09)61255-1 – volume: 169 start-page: 488 year: 2004 ident: 10.1016/j.jaci.2009.09.040_bib100 article-title: Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200309-1251OC – volume: 296 start-page: 47 year: 2006 ident: 10.1016/j.jaci.2009.09.040_bib90 article-title: Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial publication-title: JAMA doi: 10.1001/jama.296.1.47 – volume: 46 start-page: 355 year: 1991 ident: 10.1016/j.jaci.2009.09.040_bib42 article-title: Effects of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis publication-title: Thorax doi: 10.1136/thx.46.5.355 – volume: 272 start-page: 1497 year: 1994 ident: 10.1016/j.jaci.2009.09.040_bib79 article-title: Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study publication-title: JAMA doi: 10.1001/jama.1994.03520190043033 – volume: 153 start-page: 616 year: 1996 ident: 10.1016/j.jaci.2009.09.040_bib17 article-title: Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.153.2.8564107 – volume: 364 start-page: 613 year: 2004 ident: 10.1016/j.jaci.2009.09.040_bib1 article-title: Burden and clinical features of chronic obstructive pulmonary disease (COPD) publication-title: Lancet doi: 10.1016/S0140-6736(04)16855-4 – year: 2005 ident: 10.1016/j.jaci.2009.09.040_bib95 article-title: Physical training for asthma publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD001116.pub2 – volume: 52 start-page: 674 year: 1997 ident: 10.1016/j.jaci.2009.09.040_bib77 article-title: Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia publication-title: Thorax doi: 10.1136/thx.52.8.674 – volume: 356 start-page: 1480 year: 2000 ident: 10.1016/j.jaci.2009.09.040_bib39 article-title: Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(00)02872-5 – volume: 99 start-page: 1494 year: 2005 ident: 10.1016/j.jaci.2009.09.040_bib21 article-title: The effect of inhaled corticosteroids on bronchoalveolar lavage cells and IL-8 levels in stable COPD patients publication-title: Respir Med doi: 10.1016/j.rmed.2005.04.025 – volume: 109 start-page: 1156 year: 1996 ident: 10.1016/j.jaci.2009.09.040_bib37 article-title: Effects of long-term treatment with corticosteroids in COPD publication-title: Chest doi: 10.1378/chest.109.5.1156 – volume: 57 issue: 53 year: 2009 ident: 10.1016/j.jaci.2009.09.040_bib103 article-title: Recommended adult immunization schedule—United States 2009 publication-title: MMWR – volume: 2007 start-page: 889 year: 2007 ident: 10.1016/j.jaci.2009.09.040_bib4 article-title: Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China publication-title: Thorax doi: 10.1136/thx.2006.061457 – volume: 359 start-page: 1543 year: 2008 ident: 10.1016/j.jaci.2009.09.040_bib53 article-title: A 4-year trial of tiotropium in chronic obstructive pulmonary disease publication-title: N Engl J Med doi: 10.1056/NEJMoa0805800 – year: 2008 ident: 10.1016/j.jaci.2009.09.040_bib99 article-title: Vaccines for preventing influenza in people with asthma publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD000364.pub3 – volume: 1 start-page: 105 year: 2004 ident: 10.1016/j.jaci.2009.09.040_bib32 article-title: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary updated 2003 publication-title: COPD doi: 10.1081/COPD-120030163 – volume: 60 start-page: 193 year: 2005 ident: 10.1016/j.jaci.2009.09.040_bib19 article-title: Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease publication-title: Thorax doi: 10.1136/thx.2004.032516 – volume: 345 start-page: 1529 year: 2001 ident: 10.1016/j.jaci.2009.09.040_bib98 article-title: The ALA Asthma Clinical Research Centers. The safety of inactivated influenza vaccine in adults and children with asthma publication-title: N Engl J Med doi: 10.1056/NEJMoa011961 – volume: 19 start-page: 217 year: 2002 ident: 10.1016/j.jaci.2009.09.040_bib47 article-title: A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease publication-title: Eur Respir J doi: 10.1183/09031936.02.00269802 |
| SSID | ssj0009389 |
| Score | 2.0426016 |
| SecondaryResourceType | review_article |
| Snippet | For many years, chronic obstructive pulmonary disease (COPD) was considered a disease of fixed airflow obstruction for which there was no good treatment. Out... |
| SourceID | proquest pubmed pascalfrancis crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 873 |
| SubjectTerms | Acetylcholine receptors Administration, Inhalation Adrenal Cortex Hormones - administration & dosage Adrenal Cortex Hormones - therapeutic use Adrenergic beta-Antagonists - administration & dosage Adrenergic beta-Antagonists - therapeutic use airflow obstruction Albuterol - administration & dosage Albuterol - analogs & derivatives Albuterol - therapeutic use Algorithms Allergy and Immunology Androstadienes - administration & dosage Androstadienes - therapeutic use anticholinergics antioxidants Antioxidants - administration & dosage Antioxidants - therapeutic use Asthma Asthma - drug therapy Asthma - immunology Bacterial Vaccines - immunology Biological and medical sciences Bronchodilator Agents - administration & dosage Bronchodilator Agents - therapeutic use bronchodilators Chronic obstructive pulmonary disease Chronic obstructive pulmonary disease, asthma Clinical trials Clinical Trials as Topic Corticoids Drug addiction Drug therapy Fluticasone Frustration Fundamental and applied biological sciences. Psychology Fundamental immunology home oxygen Humans immunization Immunological tolerance Immunopathology Inflammation inhaled corticosteroids long-acting bronchodilators Medical sciences Mortality mucolytics oral corticosteroids Physical training Pneumology Pneumonia Pulmonary Disease, Chronic Obstructive - drug therapy Pulmonary Disease, Chronic Obstructive - immunology pulmonary rehabilitation Quality of life salmeterol Salmeterol Xinafoate Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis Scopolamine Derivatives - administration & dosage Scopolamine Derivatives - therapeutic use Smoking smoking cessation Studies Tiotropium Bromide Viral Vaccines - immunology β 2-agonists |
| Title | Management of chronic obstructive pulmonary disease: Moving beyond the asthma algorithm |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0091674909014596 https://www.clinicalkey.es/playcontent/1-s2.0-S0091674909014596 https://dx.doi.org/10.1016/j.jaci.2009.09.040 https://www.ncbi.nlm.nih.gov/pubmed/19895979 https://www.proquest.com/docview/1504816493 https://www.proquest.com/docview/21182935 https://www.proquest.com/docview/734129192 https://www.proquest.com/docview/876250324 |
| Volume | 124 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Complete Freedom Collection [SCCMFC] customDbUrl: eissn: 1097-6825 dateEnd: 20200131 omitProxy: true ssIdentifier: ssj0009389 issn: 0091-6749 databaseCode: ACRLP dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection customDbUrl: eissn: 1097-6825 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009389 issn: 0091-6749 databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: ScienceDirect Freedom Collection Journals customDbUrl: eissn: 1097-6825 dateEnd: 20200131 omitProxy: true ssIdentifier: ssj0009389 issn: 0091-6749 databaseCode: AIKHN dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1097-6825 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009389 issn: 0091-6749 databaseCode: AKRWK dateStart: 19710101 isFulltext: true providerName: Library Specific Holdings |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhgVIoJX27Tbc69Fbc2LIka3ILIWHbsjk1NDch23K7YbNe4k0hl_z2ztjyLqHZFAo-GFvyYzwjffLMfMPYR1EmskhAxNoJItU2WVwUpYirpMogress78q3TU71-Ex-PVfnW-xoyIWhsMow9vdjejdahyP7QZr7i-mUcnyBQughIU-gAqLdJvYv1OnPt-swD8hMD4Ehjal1SJzpY7wuXDkNnJW40Q-Q-yenJwvXosjqvtbFZjDaTUonu-xpQJP8sH_gZ2zLz5-zR5PgL3_BfqyjW3hT87JnwuVNEWhjf3u-uJ6hJrqrGx58NQd80v1l4EWX3MIRIXLXLn9dOu5mP5urKe6-ZGcnx9-PxnEopRCXyohljIarMq_J-ow0wktXA-SVKwQuGJQwTmhVQa3TVNclLlp16rNa5HnihNMOIdIrtj1v5v4N49JoKIypfGoqmVaVqbQC6aVwiQEFKmLpIENbBp5xKncxs0NA2YUluVMBTLC0ySRin1Z9Fj3LxoOts-HT2CF_FEc8i5PAg73y-3r5Nhhta1PbCpvYvxQrYmrV845u_vOOozt6s3o1gevAHHFyxPYGRbLrp1BE4aMlZBH7sDqNRk-eHDf3zXVrBS0LIcML8A0tckQnAhC-b25C86BKEFBH7HWvxGvZA33KHN7-55u_Y487r1uXs7nHtlGn_XsEb8ti1FnniO0cfvk2Pv0D_a5AXg |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED-6FLbBGPuut67Vw96GqS1Lsm5vpayka5OnlvVNyLa8pWRJqNPC_vudbDmhrOlg4Adj6_xxvjv95PsC-MTLRBQJ8lhZ7otq6ywuipLHVVJlmNZ1lrft20ZjNbwQ3y7l5RYc9bkwPqwy2P7OprfWOhw5CNw8WEwmPscXfQg9Jt4TKFE9gm0hySYPYPvw5HQ4XtfezXSHgjGNPUHInenCvK5sOQllK2nz_0Dun5-eLWxDXKu7dheb8Wg7Lx2_gOcBULLD7plfwpabvYLHo-Ayfw3f1wEubF6zsiuGy-ZFqBx769jiZkrCaK9_s-Cu-cJG7Y8GVrT5LYxAIrPN8ucvy-z0x_x6Qrtv4OL46_nRMA7dFOJSar6MSXdl5pRXQC00d8LWiHllC05rBsm15UpWWKs0VXVJ61aVuqzmeZ5YbpUllPQWBrP5zO0AE1phoXXlUl2JtKp0pSQKJ7hNNEqUEaQ9D00ZSo37jhdT08eUXRnPd98DE43fRBLB5xXNoiu08eDorP80pk8hJaNnaB54kCq_j8o1QW8bk5qGm8T8JVsRyBXlHfH85x337sjN6tU4LQVzgsoR7PaCZNZPIX0VHyUwi2B_dZr03jtz7MzNbxrD_coQM7oA2zAiJ4DCkRD85iF-KpQJYeoI3nVCvOY9-k-Z4_v_fPN9eDI8H52Zs5Px6Qd42jrh2hTOXRiQfLuPhOWWxV7Q1T_Fh0MJ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Management+of+chronic+obstructive+pulmonary+disease%3A+Moving+beyond+the+asthma+algorithm&rft.jtitle=Journal+of+allergy+and+clinical+immunology&rft.au=Gordon%2C+Erin%2C+MD&rft.au=Lazarus%2C+Stephen+C.%2C+MD&rft.date=2009-11-01&rft.issn=0091-6749&rft.volume=124&rft.issue=5&rft.spage=873&rft.epage=880&rft_id=info:doi/10.1016%2Fj.jaci.2009.09.040&rft.externalDBID=ECK1-s2.0-S0091674909014596&rft.externalDocID=1_s2_0_S0091674909014596 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00916749%2FS0091674909X00151%2Fcov150h.gif |